1298. Population Pharmacokinetics of Ceftazidime-avibactam among Critically-ill Patients with and without Receipt of Continuous Renal Replacement Therapy

BACKGROUND: Ceftazidime-avibactam (CAZ-AVI) is used to treat multidrug-resistant infections. There are limited pharmacokinetic (PK) data among critically-ill patients (pts) and no dosing recommendations for those receiving continuous renal replacement therapy (CRRT). METHODS: We conducted a PK study...

全面介紹

Na minha lista:
書目詳細資料
發表在:Open Forum Infect Dis
Main Authors: Kline, Ellen G, Nguyen, Minh Hong T, McCreary, Erin K, Wildfeuer, Brett, Kohl, Josh, Hughes, Kailey L, Jones, Chelsea E, Doi, Yohei, Shields, Ryan K
格式: Artigo
語言:Inglês
出版: Oxford University Press 2020
主題:
Poster Abstracts
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC7776588/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofaa439.1481
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍